Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Albis Leasing AG | 1 | 0 | 0 | 0 | €2.36 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.30 | - | - |
| Alexandria Real Estate Equ. | 7 | 0 | 0 | 0 | €107.25 | €125.92 | 17.410% |
| Alibaba Group Holding Ltd. | 1 | 0 | 0 | 0 | €8.80 | €9.00 | 2.284% |
| Alibaba Group Holding Ltd ADR | 60 | 2 | 19 | 0 | €69.70 | €98.42 | 41.203% |
| Align Technology | 16 | 2 | 2 | 0 | €230.00 | €335.27 | 45.769% |
| Allegheny Technologies | 11 | 1 | 1 | 1 | €51.52 | €60.65 | 17.729% |
| All For One Steeb AG | 6 | 1 | 2 | 0 | €57.40 | €70.00 | 21.951% |
| Alliant Energy Corp. | 4 | 0 | 0 | 0 | €47.60 | €51.20 | 7.566% |
| Allianz SE VNA | 30 | 4 | 24 | 3 | €260.00 | €285.00 | 9.615% |
| Allkem Ltd. | 2 | 0 | 0 | 0 | €5.64 | €6.00 | 6.383% |
| Allscripts Healthcare | 2 | 0 | 0 | 0 | €8.50 | €11.95 | 40.606% |
| Ally Financial Inc. | 3 | 0 | 2 | 0 | €37.23 | €41.50 | 11.469% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €237.60 | €256.11 | 7.789% |
| Alphabet Inc. A | 88 | 0 | 7 | 0 | €175.42 | €186.58 | 6.362% |
| Alphabet Inc. C | 43 | 0 | 20 | 0 | €176.98 | €190.00 | 7.357% |
| Alstom S.A. | 3 | 0 | 3 | 0 | €15.89 | €17.50 | 10.132% |
| Alstom S.A. ADR | 1 | 0 | 0 | 0 | €1.73 | - | - |
| Altair Engineering | 7 | 0 | 0 | 0 | €90.50 | €92.26 | 1.945% |
| Alten S.A. | 2 | 0 | 1 | 0 | €105.00 | €142.50 | 35.714% |
| Alteryx Inc | 10 | 2 | 0 | 0 | €44.40 | €53.05 | 19.477% |
| Altimmune | 14 | 1 | 7 | 0 | €6.18 | €12.50 | 102.364% |
| Altria Group Inc. | 7 | 1 | 1 | 0 | €43.25 | €46.13 | 6.647% |
| AlzChem Group AG | 4 | 0 | 0 | 0 | €45.60 | €50.00 | 9.649% |
| Amadeus FiRe AG | 5 | 0 | 0 | 0 | €107.60 | €145.00 | 34.758% |